New technology increases perioperative haemoglobin levels for paediatric cardiopulmonary bypass: what is the benefit?
Increasing perioperative haemoglobin level by reducing priming volume and maintaining a safe cardiopulmonary bypass (CPB) system is the aim of every perfusionist. In this study, we have compared the two membrane oxygenators and pump systems used for paediatric bypass at the Royal Children's Hospital on a regular basis since 1988. We looked at all patients who had the Cobe VPCML (Cobe Laboratories, Denver, CO, USA) and Terumo RX-05 (Terumo Corporation, Tokyo, Japan) oxygenators used for flows from 800 mL/min up to the maximum rated flow for the respective oxygenator from January 2002 until March 2004. The VPCML refers to using only the 0.4-m2 section of the oxygenator. The pump systems used were the Stöckert CAPS (Stöckert Instrumente GmbH, Munich, Germany) and Jostra HL 30 (Jostra AB, Lund, Sweden). Changing from the VPCML to the RX-05 resulted in a 37% reduction in priming volume. The introduction of the Jostra HL 30 with a custom-designed mast system reduced the priming volume by another 15%. This change in priming volume allowed a significant increase, from 6 to 34%, in the percentage of patients who received bloodless primes, and for those patients who received blood primes, an increase in haemoglobin (Hb) on bypass from 8.2 to 9.6 g/dL, on average.
Thuys
Clarke
C
Cardiac Surgery Unit, Royal Children's Hospital, Melbourne, Australia. clarke.thuys@rch.org.au
Horton
Stephen
S
Bennett
Martin
M
Augustin
Simon
S
D002315:Cardiopulmonary Bypass / Q000295:instrumentation* / Q000379:methods; D004867:Equipment Design; D006454:Hemoglobins; D006801:Humans; D010106:Oxygenators; D012680:Sensitivity and Specificity
D006454:Hemoglobins